National and Kapodistrian University of Athens
Επίδραση του ισοζυγίου ψευδαργύρου στην εξέλιξη της πειραματικά επαγώμενης ηπατικής ίνωσης
Abstract
dc:descriptionLiver cirrhosis represents a major health problem associated mainly with alcohol abuse and viral hepatis. There are several other causes of hepatic injury that can lead to cirrhosis development. The underling mechanisms participating in liver cirrhosis development have been well recognized. Apoptosis and inflammation lead to liver fibrosis and liver regeneration. These mechanisms are regulated by a number of cytokines, transcription and growth factors. Since the pathogenetic pathways encountered in the development of liver cirrhosis are fairly constant and irrelative to the causes of hepatic injury, researchers’ efforts for new treatment modalities against cirrhosis development sifts towards them. TAA administration in rats is a well established experimental model for such research. Zinc is an essential trace element, exerting important antioxidant, anti-inflammatory and antiapoptotic effects. It affects growth and development and participates in processes such as aging and cancer induction. The liver is important for the regulation of zinc homeostasis, while zinc is necessary for proper liver function. Decreased zinc levels have been referred in both acute and chronic liver disease states, and zinc deficiency has been implicated in the pathogenesis of liver diseases. Zinc supplementation offers protection in experimental animal models of acute and chronic liver injury, but these hepatoprotective properties have not been fully elucidated. In a present review, data concerning zinc homeostasis, its implication in the pathogenesis and its effect on acute and chronic liver diseases were presented. Ζinc could exert protective action against liver diseases, although up to now the underlined pathophysiological mechanisms related to zinc and liver interactions have not been defined. In order to further delineate the zinc-liver interactions in the development of liver cirrhosis, in TAA treated rats, we performed the present study. Three different zinc levels were achived in weanling male rats, by feeding them with three different diets (zinc deficient, zinc control and zinc supplemented) before and during TAA administration for three months. It’s the first time in the literature that a study with this particular experimental design was carried out. The hereby presented results, support evidence that zinc levels affect liver fibrosis development in TAA treated rats. Increased zinc levels seem to protect the liver from chronic TAA hepatotoxicity, while, on the contrary, redused zinc levels were linked with augmented TAA hepatotoxicity. It can be assumed that zinc supplementation in early stage chronic liver injury in humans can offer protection against liver cirrhosis development. The hepatoprotective effects of Zn administration could be related to redused Cu tissue levels
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stamoulis, Ioannis
- Σταμούλης, Ιωάννης
Subjects
dc:subject × 20- Ψευδάργυρος (Zn)
- Θειοακεταμίδη
- Ηπατική κίρρωση
- Ηπατική ίνωση
- Χαλκός ( Cu )
- Οξειδωτικό στρες
- Ηπατική αναγέννηση
- Απόπτωση
- Zinc (Zn)
- Thioacetamide
- Cirrhosis
- Liver fibrosis
- Cupper
- Oxidative stress
- Liver regeneration
- Apoptosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23416